anti CD19 CAR NK cells

BIOLOGICAL2 trials

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Shahid Beheshti University of Medical Sciences

Conditions

Acute Lymphocytic Leukemia in RelapseAntisynthetase SyndromeRheumatoid Arthritis

Early Phase 1

An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis

RecruitingNCT06613490

The First Affiliated Hospital with Nanjing Medical UniversityAntisynthetase Syndrome, Rheumatoid Arthritis

Start: 2025-05-20End: 2026-10-20Target: 24Updated: 2025-04-30

Phase 1

Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

Not yet recruitingNCT06631040

Shahid Beheshti University of Medical SciencesAcute Lymphocytic Leukemia in Relapse

Start: 2024-12-19End: 2026-12-30Target: 10Updated: 2024-10-08